▁def ic iency ▁in ▁ 2 0 0 2 ▁and ▁the ▁treated ▁infant ▁has ▁since ▁then ▁been ▁off ▁any ▁treatment ▁with ▁no ▁evidence ▁of ▁disease ▁for ▁more ▁than ▁ 1 6 ▁years . ▁The ▁same ▁procedure ▁was ▁used ▁by ▁the ▁team ▁in ▁Milan ▁for ▁successful ▁treatment ▁of ▁many ▁additional ▁patients ▁and ▁all ▁were ▁c ured ▁by ▁successful ▁gene ▁ther apy . ▁ ▁More ▁recently , ▁S la vin ▁introduced ▁the ▁use ▁of ▁personal ized ▁anti - can cer ▁imm un other apy ▁foc using ▁on ▁the ▁use ▁of ▁activ ated ▁don or ▁l ym ph ocy tes ▁target ed ▁against ▁cancer ▁with ▁mon oc l onal ▁and ▁bis pec ific ▁ant ib od ies ▁for ▁efficient ▁elim ination ▁of ▁cancer ▁in ▁parallel ▁with ▁induction ▁of ▁long - last ing ▁anti - can cer ▁imm unity ▁for ▁prevent ion ▁of ▁rec urrent ▁disease . ▁The ▁use ▁of ▁innov ative ▁cell - medi ated ▁imm un other apy ▁is ▁now ▁applied ▁in ▁other ▁cent ers ▁for ▁treatment ▁of ▁otherwise ▁resist ant ▁cancer , ▁such ▁as ▁in ▁patients ▁with ▁triple ▁negative ▁breast ▁cancer . ▁ ▁In ▁parallel ▁with ▁the ▁growing ▁activities ▁of ▁S la vin ' s ▁center ▁and ▁his ▁international ▁impact ▁in ▁cell ▁ther apy , ▁new ▁approaches ▁were ▁developed ▁for ▁induction ▁of ▁trans plant ation ▁toler ance ▁of ▁host - vs - gra ft ▁and ▁gra ft - vs - host ▁towards ▁developing ▁improved ▁methods ▁for ▁al log ene ic ▁blood ▁or ▁mar row ▁trans plant ation ▁as ▁well ▁as ▁trans plant ation ▁of